Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up
Purpose. The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure. We describe the safety and efficacy at long-term follow-up in adults. Methods. All consecutive adult patients that underwent ASD closure between 2008...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Interventional Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2020/7136802 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567440451567616 |
|---|---|
| author | R. J. R. Snijder L. E. Renes D. Bosshardt M. J. Suttorp J. M. ten Berg M. C. Post |
| author_facet | R. J. R. Snijder L. E. Renes D. Bosshardt M. J. Suttorp J. M. ten Berg M. C. Post |
| author_sort | R. J. R. Snijder |
| collection | DOAJ |
| description | Purpose. The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure. We describe the safety and efficacy at long-term follow-up in adults. Methods. All consecutive adult patients that underwent ASD closure between 2008 and 2015 were included. All complications were registered. Residual left-to-right shunt (LRS) was diagnosed using color-Doppler transthoracic echocardiography (TTE). Right-to-left shunting was diagnosed using contrast TTE. Successful closure was defined as no LRS at follow-up. Results. In total, 166 patients (mean age 56.7 ± 16.1 years; 62% female) underwent percutaneous ASD closure using the Occlutech Flex I (70%) or Flex II (30%) device (diameter 24 mm; range 10–40 mm) under general anaesthesia and transoesophageal echocardiographic guidance. Long-term follow-up data were available for 144 patients (87%) with a mean follow-up of 5.9 ± 2.6 years, a total of 814 patient-years. During hospitalization, device embolization occurred in three patients (1.8%) with successful extraction in all. During the long-term follow-up, 15 patients (9.8%) suffered new-onset atrial fibrillation and stroke occurred in 2.1%. There was no residual LRS at 12-month follow-up. No device embolization occurred during the long-term follow-up. Conclusion. Percutaneous ASD closure using the Occlutech device appears to be safe at long-term follow-up with a high successful closure rate at one year. |
| format | Article |
| id | doaj-art-37e6762dfb394afbbb9498b236d5b351 |
| institution | Kabale University |
| issn | 0896-4327 1540-8183 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Interventional Cardiology |
| spelling | doaj-art-37e6762dfb394afbbb9498b236d5b3512025-02-03T01:01:32ZengWileyJournal of Interventional Cardiology0896-43271540-81832020-01-01202010.1155/2020/71368027136802Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-UpR. J. R. Snijder0L. E. Renes1D. Bosshardt2M. J. Suttorp3J. M. ten Berg4M. C. Post5Department of Cardiology, St. Antonius Hospital, Nieuwegein, NetherlandsDepartment of Emergency Medicine, St. Antonius Hospital, Nieuwegein, NetherlandsDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, NetherlandsDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, NetherlandsDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, NetherlandsDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, NetherlandsPurpose. The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure. We describe the safety and efficacy at long-term follow-up in adults. Methods. All consecutive adult patients that underwent ASD closure between 2008 and 2015 were included. All complications were registered. Residual left-to-right shunt (LRS) was diagnosed using color-Doppler transthoracic echocardiography (TTE). Right-to-left shunting was diagnosed using contrast TTE. Successful closure was defined as no LRS at follow-up. Results. In total, 166 patients (mean age 56.7 ± 16.1 years; 62% female) underwent percutaneous ASD closure using the Occlutech Flex I (70%) or Flex II (30%) device (diameter 24 mm; range 10–40 mm) under general anaesthesia and transoesophageal echocardiographic guidance. Long-term follow-up data were available for 144 patients (87%) with a mean follow-up of 5.9 ± 2.6 years, a total of 814 patient-years. During hospitalization, device embolization occurred in three patients (1.8%) with successful extraction in all. During the long-term follow-up, 15 patients (9.8%) suffered new-onset atrial fibrillation and stroke occurred in 2.1%. There was no residual LRS at 12-month follow-up. No device embolization occurred during the long-term follow-up. Conclusion. Percutaneous ASD closure using the Occlutech device appears to be safe at long-term follow-up with a high successful closure rate at one year.http://dx.doi.org/10.1155/2020/7136802 |
| spellingShingle | R. J. R. Snijder L. E. Renes D. Bosshardt M. J. Suttorp J. M. ten Berg M. C. Post Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up Journal of Interventional Cardiology |
| title | Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up |
| title_full | Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up |
| title_fullStr | Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up |
| title_full_unstemmed | Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up |
| title_short | Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up |
| title_sort | percutaneous atrial septal defect closure using the occlutech figulla device in adults more than 800 patient years of follow up |
| url | http://dx.doi.org/10.1155/2020/7136802 |
| work_keys_str_mv | AT rjrsnijder percutaneousatrialseptaldefectclosureusingtheocclutechfigulladeviceinadultsmorethan800patientyearsoffollowup AT lerenes percutaneousatrialseptaldefectclosureusingtheocclutechfigulladeviceinadultsmorethan800patientyearsoffollowup AT dbosshardt percutaneousatrialseptaldefectclosureusingtheocclutechfigulladeviceinadultsmorethan800patientyearsoffollowup AT mjsuttorp percutaneousatrialseptaldefectclosureusingtheocclutechfigulladeviceinadultsmorethan800patientyearsoffollowup AT jmtenberg percutaneousatrialseptaldefectclosureusingtheocclutechfigulladeviceinadultsmorethan800patientyearsoffollowup AT mcpost percutaneousatrialseptaldefectclosureusingtheocclutechfigulladeviceinadultsmorethan800patientyearsoffollowup |